Live Dana-Farber Cancer Institute updates

Live Dana-Farber Cancer Institute news coverage of developments with the latest updates. Stay on top of latest Dana-Farber Cancer Institute news stories and find out what just happened, what is going on with Dana-Farber Cancer Institute. The latest real-time news updates and headlines on Dana-Farber Cancer Institute
Sox9 Protein Triggers Colorectal Cancer Time Travel
Sox9 Protein Leads to Colorectal Cancer Through Time Travel
Scientists Develop Mouse Avatars for Multiple Myeloma Treatment
Joshua Kraft Urges Prostate Cancer Screening After Personal Treatment
Second Transatlantic Exchanges: Oncology Conference at Dana-Farber, Gustave Roussy
Lynch Syndrome Awareness Day: Cancer Risk Soars with Common Genetic Condition
Faster Cancer Diagnoses for Underserved: Community Health Centers Help
Community Health Center Boosts Cancer Diagnosis for Underserved
Researchers Find Cause of T Cell Exhaustion
Understanding, Preventing, Treating Young-Onset Colorectal Cancer: Dana-Farber Study
Dana-Farber Paves Way for Young-Onset Colorectal Cancer Treatment
Novel Drug Resistance in Acute Leukemia Explained by Study
Cause of Resistance to Novel Drug in Acute Leukemia Discovered
Novobiocin Fights BRCA-Mutated Cancer Cells Inside and Out: Study
New drugs may block COVID-19 variants
New drugs could thwart COVID-19 variants
Research finds new drugs could prevent COVID variants
Dana-Farber In-House Lawyer Krietta Bowens Jones Honored for 2023
Dana-Farber Highlights Novel Therapies for Colorectal Cancer
10-Year Study Confirms High Success of HER2+ Breast Cancer Therapy
Immunotherapy Combo Boosts Survival in Advanced Kidney Cancer
Society of Nuclear Medicine Releases SSTR PET Imaging Guidelines for Neuroendocrine Tumors
COVID-19 Vaccine Improves Outcomes for Cancer Patients
Dana-Farber’s Fitzpatrick Selected for Boston Bar Program
CAR-T Immunotherapy Personalized for Cancer
New Study Suggests Way to Combat Cancer
Esteemed Ludwig Scientific Advisor Christopher Walsh Dies at 79
FDA Approves New Therapy for Metastatic Breast Cancer from Dana-Farber
Four Join Dana-Farber Board of Trustees
1/3 of Drug-Resistant Ovarian Cancer Patients Find Remission with Conjugate Therapy
Targeting cancer with multidrug nanoparticle
Nanoparticle Could Aid in Cancer Treatment
Research Links Enzymes to Proteins in Cells
Novel Immunotherapy Combos Fight Colorectal Cancer
FDA Approves Next-Gen Drug for Relapsed CLL After Dana-Farber Study
Mapping Colorectal Cancer to Uncover Dynamics
Unprecedented Insight Into Colorectal Cancer
Dana-Farber Researcher Wins Victoria Mock Award
Molecular Tumor Board Aids Cancer Precision Medicine
Oncology Researcher to Join Rutgers Global Health Institute
Biochemist revealed molecular basis of antibiotic resistance
NEIDL Finds Weak Spot in Covid, Could Guide Vaccine Advances
Link between Inflammation & Blood Cancer Severity Found
Research Reveals Inequality in Access to Opioids for Elderly Cancer Patients
T Cells Labeled with Cytokines Boost Cancer Immunotherapy
Mapping Genetic Evolution from CLL to Richter’s Syndrome
Molecular Differences between Primary Breast Cancer and Metastases Identified
Exercise Found to Help Preserve Physical Fitness as We Age